(Portland, Oregon) – OIA Global, a leading logistics, packaging and material sourcing provider, and EndoChoice, Inc., an innovative manufacturer of endoscopic imaging systems, devices and infection control products have launched a new logistics program to simplify product packaging, reduce shipping costs and build sustainability.
“This new partnership provides EndoChoice with a tremendous opportunity to better fulfill our core mission of serving the Gastrointestinal Caregiver," stated John T. Arant, Senior Director, Global Supply Chain at EndoChoice. “Because of our focus on the manufacturing and commercialization of technology for our life-saving medical equipment, our supply chain is a critical component of our value proposition,” he added.
EndoChoice has over 2,500 customers in the United States, including hospitals and clinics that require short delivery windows. Through distribution partnerships, the platform company serves an additional 30 countries and is recognized worldwide for its high standards of product integrity.
"While EndoChoice maintains its commitment to innovating the healthcare field, we are proud to be part of the infrastructure that is reengineering and optimizing the outbound packaging process, which has reduced transportation costs by over 20%," said Heidi Bassano, Global Account Manager, Healthcare at OIA Global.
Arant also noted the success this program has had in reducing the carbon footprint at EndoChoice, as they have decreased the amount of dunnage and packaging materials needed to ship products while improving packaging integrity. “Sustainability is an important initiative for our company, and while we are pleased with the supply chain efficiencies achieved by OIA, we are also thrilled to see the impact it has had on helping us be better stewards of the environment,” said Arant.
About OIA Global:
Since its founding in 1988, OIA has grown into a $1 billion supply chain management leader, delivering clients a unique combination of global logistics, materials sourcing, and packaging solutions. With over 1000 professionals in 60+ owned offices, and a worldwide presence in 26 countries, OIA designs innovative solutions that optimize supply chains around the world. OIA is privately owned by Indianapolis-based LDI, Ltd., with more than a century of experience funding and operating high potential, middle-market companies. For more information please visit www.oiaglobal.com and www.ldiltd.com.
Based near Atlanta, Georgia, EndoChoice is a medtech company focused on the manufacturing and commercialization of platform technologies including endoscopic imaging systems, devices and infection control products and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. EndoChoice leverages its direct sales organization to serve more than 2,500 customers in the United States and works with distribution partners in 30 countries. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.